Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

REGN Regeneron Pharmaceuticals

Market Closed 04-10 16:00:00 EDT

748.87

-18.98

-2.47%

盘后749.36

+0.49+0.07%

19:55 EDT

High771.48	Low739.09	Vol751.46K
Open771.48	D1 Closing767.85	Amplitude4.22%
Mkt Cap79.17B	Tradable Cap77.36B	Total Shares105.72M
T/O563.24M	T/O Rate0.73%	Tradable Shares103.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":748.87,"timestamp":1775851200000,"preClose":767.85,"halted":0,"volume":751457,"hourTrading":{"tag":"盘后","latestPrice":749.36,"preClose":748.87,"latestTime":"19:55 EDT","volume":115688,"amount":86630655.8726,"timestamp":1775865340213,"change":0.49,"changeRate":0.000654,"amplitude":0.000654},"delay":0,"changeRate":-0.024718369473204424,"floatShares":103302739,"shares":105719806,"eps":41.59414,"marketStatus":"Market Closed","change":-18.98,"latestTime":"04-10 16:00:00 EDT","open":771.48,"high":771.48,"low":739.09,"amount":563242984.33935,"amplitude":0.042183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":41.59414,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":767.85,"dividendRate":0.0047,"preHourTrading":{"tag":"盘前","latestPrice":767.44,"preClose":767.85,"latestTime":"09:28 EDT","volume":190,"amount":145618.071,"timestamp":1775827695639,"change":-0.41,"changeRate":-0.000534,"amplitude":0.012314},"postHourTrading":{"tag":"盘后","latestPrice":749.36,"preClose":748.87,"latestTime":"19:55 EDT","volume":115688,"amount":86630655.8726,"timestamp":1775865340213,"change":0.49,"changeRate":0.000654,"amplitude":0.000654},"volumeRatio":1.1554503439012367,"impliedVol":0.4778,"impliedVolPercentile":0.956},"requestUrl":"/m/hq/s/REGN/tweets","defaultTab":"tweets","newsList":[{"id":"2626714824","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2626714824","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626714824?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:42","pubTimestamp":1775853720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  shed 2.47% to $748.87 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.11% to 6,816.89 and Dow Jones Industrial Average  falling 0.56% to 47,916.57.This was the stock's second consecutive day of losses.Regeneron Pharmaceuticals Inc. closed 8.80% below its 52-week high of $821.11, which the company achieved on January 9th.The stock underperformed when compared to some of its competitors Friday, as Amgen Inc.  fell 1.29% to $351.02, Moderna Inc.  fell 0.62% to $50.96, and Gilead Sciences Inc.  fell 2.18% to $138.99.Trading volume  eclipsed its 50-day average volume of 690,537.Data source: Dow Jones Market Data, FactSet. Data compiled April 10, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones New","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626811900","title":"Regeneron Pharma Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2626811900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626811900?lang=en_us&edition=fundamental","pubTime":"2026-04-10 23:56","pubTimestamp":1775836560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2026 11:56 ET (15:56 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU0109394709.USD","LU0114720955.EUR","LU0823434583.USD","LU2089984988.USD","LU2237438978.USD","BK4585","LU2106854487.HKD","LU1974910355.USD","LU0320765992.SGD","LU2362541513.USD","LU0882574055.USD","LU0058720904.USD","LU0823416689.USD","LU0053666078.USD","LU0289739699.SGD","LU1917777945.USD","LU2023250504.SGD","BK4139","LU2362540622.SGD","REGN","LU0889565916.HKD","LU2468319806.SGD","LU0823434740.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626118895","title":"Regeneron price target raised to $796 from $769 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2626118895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626118895?lang=en_us&edition=fundamental","pubTime":"2026-04-10 20:56","pubTimestamp":1775825790,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Regeneron (REGN) to $796 from $769 and keeps an Equal Weight rating on the shares. The firm adjust...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-raised-to-796-from-769-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-raised-to-796-from-769-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0823416689.USD","BK4139","LU0320765646.SGD","LU0267386448.USD","LU2347655156.SGD","LU0912757837.SGD","LU2362541273.HKD","LU0889565916.HKD","LU2023250504.SGD","REGN","LU0006306889.USD","LU1244550577.SGD","LU0109394709.USD","LU2089284900.SGD","LU0098860793.USD","LU0234570918.USD","LU0795875086.SGD","BK4516","LU2468319806.SGD","LU2089283258.USD","LU2089984988.USD","LU0882574139.USD","LU0158827948.USD","BK4127","LU1363072403.SGD","LU2106854487.HKD","LU1668664300.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU1244550221.USD","LU0795875169.SGD","LU2023251221.USD","LU0114720955.EUR","LU0106831901.USD","LU2357305700.SGD","LU2362541513.USD","LU2133065610.SGD","LU1791710400.SGD","LU1720051017.SGD","LU0557290698.USD","BK4534","LU0882574055.USD","LU0058720904.USD","LU0106261372.USD","LU2271345857.HKD","IE00BKVL7J92.USD","LU1791710582.SGD","LU0289739699.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626941251","title":"Piper Sandler Reaffirms Their Buy Rating on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626941251","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626941251?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:15","pubTimestamp":1775819728,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on Regeneron today and set a price target of $875.00. Amin covers the Healthcare sector, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626192733","title":"Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2626192733","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626192733?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:41","pubTimestamp":1775680860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  advanced 2.01% to $775.53 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 2.51% to 6,782.81 and the Dow Jones Industrial Average  rising 2.85% to 47,909.92.Regeneron Pharmaceuticals Inc. closed 5.55% below its 52-week high of $821.11, which the company reached on January 9th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc.  rose 2.89% to $349.81, Moderna Inc.  rose 3.97% to $52.10, and Gilead Sciences Inc.  rose 1.97% to $141.54.Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625731942","title":"Bernstein Adjusts Regeneron Pharmaceuticals Price Target to $921 From $925, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2625731942","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625731942?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:50","pubTimestamp":1775656215,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $882.58, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625594243","title":"Regeneron Pharma Is Maintained at Outperform by Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2625594243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625594243?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:45","pubTimestamp":1775655900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2026 09:45 ET (13:45 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0823434740.USD","LU2362541513.USD","LU0114720955.EUR","LU0109394709.USD","LU0823416689.USD","BK4139","LU0053666078.USD","LU0320765992.SGD","LU2468319806.SGD","LU1917777945.USD","LU0058720904.USD","LU2089984988.USD","LU0889565916.HKD","LU1974910355.USD","LU2362540622.SGD","LU0882574055.USD","BK4585","LU0823434583.USD","LU2106854487.HKD","LU0289739699.SGD","LU2023250504.SGD","LU2362541273.HKD","LU2237438978.USD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625019946","title":"Regeneron Expects $0.81 per Share Net Income Impact From $102 Million R&D Charges for Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2625019946","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625019946?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:16","pubTimestamp":1775650570,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) said Wednesday that it expects Q1 net income to be negatively impacted by about $0.81 per diluted share due to an acquired in-process research and development charge o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0114720955.EUR","LU2237438978.USD","LU0053666078.USD","LU0823416689.USD","BK4585","LU2362541273.HKD","LU2362541513.USD","REGN","LU0889565916.HKD","LU2468319806.SGD","LU2106854487.HKD","LU0320765992.SGD","LU0823434740.USD","LU2023250504.SGD","LU0109394709.USD","LU0823434583.USD","LU1917777945.USD","LU2362540622.SGD","LU0289739699.SGD","BK4139","LU1974910355.USD","LU0882574055.USD","BK4588","LU0058720904.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625945970","title":"Regeneron price target lowered to $921 from $925 at Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2625945970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625945970?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:31","pubTimestamp":1775647882,"startTime":"0","endTime":"0","summary":"Bernstein lowered the firm’s price target on Regeneron (REGN) to $921 from $925 and keeps an Outperform rating on the shares. The firm notes the co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-lowered-to-921-from-925-at-bernstein-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-lowered-to-921-from-925-at-bernstein-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0114720955.EUR","BK4588","LU0289739699.SGD","LU1974910355.USD","BK4585","LU2237438978.USD","LU0823416689.USD","REGN","LU2106854487.HKD","LU0320765992.SGD","LU2468319806.SGD","LU1917777945.USD","LU0058720904.USD","LU0823434740.USD","LU2089984988.USD","LU0109394709.USD","LU2362540622.SGD","LU2362541513.USD","LU0823434583.USD","BK4139","LU0889565916.HKD","LU0882574055.USD","LU2362541273.HKD","LU0053666078.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943504","title":"Regeneron Pharmaceuticals Inc - Expects Q1 2026 Gaap and Non-Gaap Ipr&D Charge of $102 Mln Pre-Tax - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625943504?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:07","pubTimestamp":1775646441,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40Q1GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU2023250504.SGD","BK4139","LU0882574055.USD","LU2237438978.USD","LU2362540622.SGD","LU0114720955.EUR","LU2362541273.HKD","LU0053666078.USD","LU0889565916.HKD","LU1917777945.USD","LU2089984988.USD","REGN","LU2362541513.USD","LU0320765992.SGD","LU2468319806.SGD","LU0823434583.USD","LU2106854487.HKD","LU0823416689.USD","LU0109394709.USD","BK4588","BK4585","LU0823434740.USD","LU1974910355.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625681943","title":"Regeneron expects Q1 acquired IPR&D charge of $102 million, cutting EPS by $0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2625681943","media":"Reuters","labels":["dataReport","merge","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625681943?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:07","pubTimestamp":1775646424,"startTime":"0","endTime":"0","summary":"Regeneron expects first-quarter 2026 results to include acquired in-process R&D charge of about $102 million on a pre-tax basis.Charge is forecast to cut GAAP net income per diluted share by about $0.81.Estimate reflects premiums paid on equity securities bought for collaboration and licensing deals.Outlook also includes upfront payments and development milestones tied to those agreements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regeneron Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained ther","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL63K962:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0882574055.USD","LU2089984988.USD","LU1974910355.USD","LU0114720955.EUR","LU0109394709.USD","LU0320765992.SGD","LU0053666078.USD","BK4139","BK4585","LU0058720904.USD","LU2468319806.SGD","LU0289739699.SGD","LU0823434740.USD","LU2362541273.HKD","LU2237438978.USD","LU2362541513.USD","REGN","LU0823416689.USD","LU2106854487.HKD","LU1917777945.USD","LU0889565916.HKD","BK4588","LU2362540622.SGD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625528912","title":"Regeneron Pharmaceuticals Inc : Bernstein Cuts Target Price to $921 From $925","url":"https://stock-news.laohu8.com/highlight/detail?id=2625528912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625528912?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:37","pubTimestamp":1775641073,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40R0MY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU2089984988.USD","LU2106854487.HKD","BK4585","LU0823434583.USD","LU0053666078.USD","LU0114720955.EUR","LU2237438978.USD","LU1917777945.USD","BK4588","LU0289739699.SGD","LU0889565916.HKD","LU0109394709.USD","LU2362541273.HKD","BK4139","LU2023250504.SGD","LU2362541513.USD","LU0823434740.USD","LU0058720904.USD","LU0320765992.SGD","LU0823416689.USD","LU0882574055.USD","LU2362540622.SGD","LU1974910355.USD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625195301","title":"RBC Adjusts Price Target on Regeneron Pharmaceuticals to $779 From $765, Maintains Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2625195301","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625195301?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:06","pubTimestamp":1775567174,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $882.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625933024","title":"Assessing Regeneron Pharmaceuticals (REGN) Valuation After FDA Approval Extends EYLEA HD Dosing Intervals","url":"https://stock-news.laohu8.com/highlight/detail?id=2625933024","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625933024?lang=en_us&edition=fundamental","pubTime":"2026-04-07 15:22","pubTimestamp":1775546531,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) is back in focus after the US FDA approved extended dosing intervals for EYLEA HD in wet age related macular degeneration and diabetic macular edema, easing treatment schedules for eligible patients.\nSee our latest analysis for Regeneron Pharmaceuticals.\nAt a share price of $763.04, Regeneron has a 1 year total shareholder return of 33.94%, while its year to date share price return is slightly negative. This suggests that longer term momentum has been strong...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/assessing-regeneron-pharmaceuticals-regn-valuation-after-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/assessing-regeneron-pharmaceuticals-regn-valuation-after-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1496350502.SGD","BK4504","REGN","BK4588","LU0058720904.USD","LU0689472784.USD","LU0820562030.AUD","LU1917777945.USD","LU1551013342.USD","LU1989772840.SGD","LU2461242641.AUD","SG9999001440.SGD","BK4550","BK4533","LU0823434583.USD","LU0882574055.USD","LU1974910355.USD","LU1914381329.SGD","LU2756315664.SGD","LU0823416689.USD","LU1035775433.USD","LU1093756325.SGD","LU2362540622.SGD","LU1674673428.USD","LU0114720955.EUR","LU0823434740.USD","BK4534","LU0942090050.USD","LU1674673691.USD","LU2106854487.HKD","LU1989772923.USD","LU2089984988.USD","LU1236620750.USD","HD","LU1551013425.SGD","LU0820561909.HKD","LU0889565916.HKD","LABU","LU2237438978.USD","BK4581","LU0109394709.USD","LU2756315318.SGD","LU0289739699.SGD","BK4083","LU2361044949.HKD","BK4567","LU1236620834.HKD","LU2362541273.HKD","LU0238689110.USD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625322617","title":"Regeneron’s EYLEA HD Label Update Shifts Retinal Care And Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2625322617","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625322617?lang=en_us&edition=fundamental","pubTime":"2026-04-05 07:28","pubTimestamp":1775345297,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (NasdaqGS:REGN) received FDA approval to extend EYLEA HD dosing intervals for wet age-related macular degeneration and diabetic macular edema up to every 20 weeks.\nThe decision is based on two year efficacy and safety data and updates the product label to reflect longer potential intervals between injections.\nThe change may reduce treatment burden for eligible patients and could influence how eye specialists plan long term care for wAMD and DME.\n\nRegeneron enters...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regenerons-eylea-hd-label-update-shifts-retinal-care-and-com","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regenerons-eylea-hd-label-update-shifts-retinal-care-and-com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4533","LU2756315318.SGD","LU0354030438.USD","LU0320765992.SGD","LU2362541513.USD","BK4550","LU0943347566.SGD","LU2756315664.SGD","SG9999001440.SGD","LU0689472784.USD","LU1674673428.USD","LU2361045086.USD","LU0889565916.HKD","LU1674673691.USD","LU1778281490.HKD","BK4585","IE00B1XK9C88.USD","LU0820562030.AUD","HD","LU1929549753.HKD","LU0234572021.USD","BK4566","BK4083","LU0289739699.SGD","IE00BWXC8680.SGD","IE00BZ1G4Q59.USD","LU0058720904.USD","REGN","LU0882574055.USD","LU0079474960.USD","LU0823411888.USD","LU2361044865.SGD","BK4567","LU1989772840.SGD","LU2106854487.HKD","LU1236620834.HKD","LU2362541273.HKD","LU0868494708.USD","LU0238689110.USD","LU1093756325.SGD","LU1551013425.SGD","LU0942090050.USD","LU0114720955.EUR","LU0868494617.USD","LU1496350502.SGD","IE00BSNM7G36.USD","LU1974910355.USD","LU0823434583.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624661094","title":"Regeneron director Arthur Ryan reports REGN share sale worth $0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624661094","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624661094?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:02","pubTimestamp":1775246554,"startTime":"0","endTime":"0","summary":"Regeneron director Arthur Ryan reported sale of 100 shares of common stock on April 1, 2026.Transaction prices ranged from USD 771.32 to USD 779.71 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regeneron Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL2RZXnN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Regeneron director Arthur Ryan reports REGN share sale worth $0 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU0823434740.USD","BK4585","LU0823416689.USD","LU0882574055.USD","LU0109394709.USD","LU0053666078.USD","LU2089984988.USD","LU2362540622.SGD","LU0058720904.USD","LU2106854487.HKD","LU0289739699.SGD","LU0823434583.USD","REGN","LU0114720955.EUR","LU0320765992.SGD","LU1917777945.USD","LU1974910355.USD","BK4139","LU2468319806.SGD","LU2023250504.SGD","LU2237438978.USD","LU0889565916.HKD","BK4588","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156527754","title":"Trump Will Impose 100% Tariff on Some Patented Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1156527754","media":"Tiger Newspress","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156527754?lang=en_us&edition=fundamental","pubTime":"2026-04-03 07:16","pubTimestamp":1775171812,"startTime":"0","endTime":"0","summary":"The Trump administration will impose tariffs of as much as 100% on certain imported medicines, albeit with several major exemptions, a maneuver to pressure drugmakers to manufacture more in the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4e63e9b5baa83146ad37e2bf910d1394","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","NVAX","VIR","ABBV","LLY","AMGN","MRK","GSK","BMY","MRNA","JNJ","SNY","ABT","BNTX","AZN","GILD","PFE","NVS","VERU","NVO","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624680582","title":"BRIEF-Trinetx Collaborates With Regeneron To Access De-Identified Electronic Health Records Of 300 Million Patients To Drive Research And Product Development In Life Sciences And Digital Health Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2624680582","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624680582?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:31","pubTimestamp":1775165475,"startTime":"0","endTime":"0","summary":"BRIEF-Trinetx Collaborates With Regeneron To Access De-Identified Electronic Health Records Of 300 Million Patients To Drive Research And Product Development In Life Sciences And Digital Health Soluti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUABCPWKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0823416689.USD","BK4139","LU2362541273.HKD","LU0889565916.HKD","LU2023250504.SGD","LU0823434583.USD","REGN","LU0109394709.USD","LU2362540622.SGD","LU2468319806.SGD","LU0053666078.USD","LU2089984988.USD","LU2106854487.HKD","LU1917777945.USD","LU0320765992.SGD","BK4588","LU2237438978.USD","LU1974910355.USD","LU0114720955.EUR","LU2362541513.USD","LU0882574055.USD","LU0058720904.USD","LU0289739699.SGD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624368785","title":"Regeneron to invest up to $200M in TriNetX as part of strategic collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2624368785","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624368785?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:35","pubTimestamp":1775162141,"startTime":"0","endTime":"0","summary":"TriNetX and Regeneron (REGN) Pharmaceuticals announced a strategic collaboration to support Regeneron’s capabilities in drug discovery and developm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-to-invest-up-to-200m-in-trinetx-as-part-of-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-to-invest-up-to-200m-in-trinetx-as-part-of-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823434740.USD","LU2106854487.HKD","LU1917777945.USD","LU2362541513.USD","LU0114720955.EUR","LU0889565916.HKD","BK4588","LU0109394709.USD","LU0823416689.USD","LU2362541273.HKD","REGN","LU2468319806.SGD","LU0053666078.USD","LU0058720904.USD","LU2237438978.USD","LU0320765992.SGD","LU1974910355.USD","BK4139","LU0289739699.SGD","LU2023250504.SGD","LU0882574055.USD","LU2089984988.USD","BK4585","LU0823434583.USD","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568245","title":"Regeneron, TriNetX partner to link genomic data with EHRs from 300 million patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568245","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624568245?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:31","pubTimestamp":1775161883,"startTime":"0","endTime":"0","summary":"Regeneron entered strategic collaboration with TriNetX to access de-identified electronic health records data covering about 300 million patients.Deal grants Regeneron exclusive opportunity to link its genomic and proteomic cohorts with TriNetX phenotypic network to expand its EHR-linked molecular database.TriNetX will provide licensed access to current and future de-identified data, including about 170 million US patients.Regeneron plans to use expanded dataset to support drug discovery, development programs, AI training, digital health initiatives.Regeneron will invest up to 200 million in TriNetX.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL8dYbhF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0889565916.HKD","LU0823416689.USD","LU2106854487.HKD","LU0114720955.EUR","LU0882574055.USD","BK4588","LU2362541513.USD","LU0289739699.SGD","LU1917777945.USD","BK4585","LU0058720904.USD","LU2362540622.SGD","LU0823434583.USD","LU1974910355.USD","LU2362541273.HKD","LU0109394709.USD","LU2468319806.SGD","LU2089984988.USD","LU0823434740.USD","LU0320765992.SGD","LU2237438978.USD","LU0053666078.USD","LU2023250504.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regeneron.com","stockEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.0333},{"period":"3month","weight":-0.0599},{"period":"6month","weight":0.3263},{"period":"1year","weight":0.3706},{"period":"ytd","weight":-0.0298}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.514286,"avgChangeRate":0.03675},{"month":2,"riseRate":0.428571,"avgChangeRate":0.086855},{"month":3,"riseRate":0.457143,"avgChangeRate":-0.043382},{"month":4,"riseRate":0.457143,"avgChangeRate":0.015821},{"month":5,"riseRate":0.628571,"avgChangeRate":0.057479},{"month":6,"riseRate":0.428571,"avgChangeRate":0.006745},{"month":7,"riseRate":0.657143,"avgChangeRate":0.052646},{"month":8,"riseRate":0.542857,"avgChangeRate":0.022877},{"month":9,"riseRate":0.457143,"avgChangeRate":0.023281},{"month":10,"riseRate":0.4,"avgChangeRate":-0.00141},{"month":11,"riseRate":0.542857,"avgChangeRate":0.046018},{"month":12,"riseRate":0.485714,"avgChangeRate":0.043803}],"exchange":"NASDAQ","name":"Regeneron Pharmaceuticals","nameEN":"Regeneron Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Regeneron Pharmaceuticals,REGN,Regeneron Pharmaceuticals股票,Regeneron Pharmaceuticals股票老虎,Regeneron Pharmaceuticals股票老虎国际,Regeneron Pharmaceuticals行情,Regeneron Pharmaceuticals股票行情,Regeneron Pharmaceuticals股价,Regeneron Pharmaceuticals股市,Regeneron Pharmaceuticals股票价格,Regeneron Pharmaceuticals股票交易,Regeneron Pharmaceuticals股票购买,Regeneron Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}